Haemodynamic determinants of quality of life in chronic heart failure.


Journal

BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539

Informations de publication

Date de publication:
16 09 2022
Historique:
received: 02 06 2022
accepted: 18 08 2022
entrez: 16 9 2022
pubmed: 17 9 2022
medline: 21 9 2022
Statut: epublish

Résumé

Heart failure patients demonstrate reduced functional capacity, hemodynamic function, and quality of life (QOL) which are associated with high mortality and morbidity rate. The aim of the present study was to assess the relationship between functional capacity, hemodynamic response to exercise and QOL in chronic heart failure. A single-centre prospective study recruited 42 chronic heart failure patients (11 females, mean age 60 ± 10 years) with reduced left ventricular ejection fraction (LVEF = 23 ± 7%). All participants completed a maximal graded cardiopulmonary exercise test with non-invasive hemodynamic (bioreactance) monitoring. QOL was assessed using Minnesota Living with Heart Failure Questionnaire. The average value of QOL score was 40 ± 23. There was a significant negative relationship between the QOL and peak O Peak O

Sections du résumé

BACKGROUND
Heart failure patients demonstrate reduced functional capacity, hemodynamic function, and quality of life (QOL) which are associated with high mortality and morbidity rate. The aim of the present study was to assess the relationship between functional capacity, hemodynamic response to exercise and QOL in chronic heart failure.
METHODS
A single-centre prospective study recruited 42 chronic heart failure patients (11 females, mean age 60 ± 10 years) with reduced left ventricular ejection fraction (LVEF = 23 ± 7%). All participants completed a maximal graded cardiopulmonary exercise test with non-invasive hemodynamic (bioreactance) monitoring. QOL was assessed using Minnesota Living with Heart Failure Questionnaire.
RESULTS
The average value of QOL score was 40 ± 23. There was a significant negative relationship between the QOL and peak O
CONCLUSION
Peak O

Identifiants

pubmed: 36114473
doi: 10.1186/s12872-022-02829-w
pii: 10.1186/s12872-022-02829-w
pmc: PMC9479234
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

412

Informations de copyright

© 2022. The Author(s).

Références

Eur Heart J. 2001 Aug;22(16):1496-503
pubmed: 11482923
Eur J Prev Cardiol. 2017 Dec;24(18):1979-1987
pubmed: 29086584
Artif Organs. 2018 Jul;42(7):686-694
pubmed: 29436010
Int Heart J. 2012;53(5):293-8
pubmed: 23038090
J Am Coll Cardiol. 2019 May 7;73(17):2209-2225
pubmed: 31047010
Circulation. 1992 Jun;85(6):2119-31
pubmed: 1591831
JAMA. 2009 Apr 8;301(14):1439-50
pubmed: 19351941
Circ Heart Fail. 2009 Jan;2(1):33-8
pubmed: 19808313
Nurs Res. 2002 Jul-Aug;51(4):209-18
pubmed: 12131233
JACC Heart Fail. 2015 Oct;3(10):803-14
pubmed: 26449998
Circ Heart Fail. 2015 Mar;8(2):286-94
pubmed: 25344549
Arq Bras Cardiol. 2010 Aug;95(2):238-43
pubmed: 20658089
Clin Sci (Lond). 2012 Feb;122(4):175-81
pubmed: 21883095
Int J Cardiol. 2013 Jul 15;167(1):157-61
pubmed: 22244484
Circulation. 1989 Feb;79(2):324-9
pubmed: 2914350
J Cardiopulm Rehabil Prev. 2010 Mar-Apr;30(2):101-5
pubmed: 19952769
Heart. 2002 Mar;87(3):235-41
pubmed: 11847161
Int J Sports Med. 2019 Dec;40(13):813-817
pubmed: 31614381
Br J Anaesth. 2015 Sep;115(3):386-91
pubmed: 25659999
Eur J Heart Fail. 2002 Jun;4(3):289-95
pubmed: 12034154
Int J Cardiol. 2010 Dec 3;145(3):526-8
pubmed: 20452691
Open Heart. 2017 Jul 28;4(2):e000632
pubmed: 28878952
Circulation. 1999 Mar 9;99(9):1173-82
pubmed: 10069785
Am J Cardiol. 2020 Jan 1;125(1):76-81
pubmed: 31703805
Lancet. 1991 Mar 30;337(8744):771-3
pubmed: 1672400

Auteurs

Serlie Fatrin (S)

Cardiovascular Research Theme, Translational and Clinical, and Biosciences Research Institutes, Medical School, Faculty of Medical Sciences, Newcastle University, William Leech Building 4th Floor, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.

Nduka C Okwose (NC)

Cardiovascular Research Theme, Translational and Clinical, and Biosciences Research Institutes, Medical School, Faculty of Medical Sciences, Newcastle University, William Leech Building 4th Floor, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.
Research Centre (CSELS), Institute for Health and Wellbeing, Faculty of Health and Life Scurnces, Coventry University, Coventry, UK.

Kristian Bailey (K)

Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Lazar Velicki (L)

Institute of Cardiovascular Diseases Vojvodina, University of Novi Sad, Novi Sad, Serbia.

Dejana Popovic (D)

Department of Cardiology, Medical School, Clinical Centre of Serbia, University of Belgrade, Belgrade, Serbia.

Arsen Ristic (A)

Department of Cardiology, Medical School, Clinical Centre of Serbia, University of Belgrade, Belgrade, Serbia.

Petar M Seferovic (PM)

Department of Cardiology, Medical School, Clinical Centre of Serbia, University of Belgrade, Belgrade, Serbia.

Guy A MacGowan (GA)

Cardiovascular Research Theme, Translational and Clinical, and Biosciences Research Institutes, Medical School, Faculty of Medical Sciences, Newcastle University, William Leech Building 4th Floor, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK.
Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Djordje G Jakovljevic (DG)

Cardiovascular Research Theme, Translational and Clinical, and Biosciences Research Institutes, Medical School, Faculty of Medical Sciences, Newcastle University, William Leech Building 4th Floor, Framlington Place, Newcastle upon Tyne, NE2 4HH, UK. djordje.jakovljevic@newcastle.ac.uk.
Research Centre (CSELS), Institute for Health and Wellbeing, Faculty of Health and Life Scurnces, Coventry University, Coventry, UK. djordje.jakovljevic@newcastle.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH